Distinct alpha-L-fucosidase isoenzyme profiles in human leukemic cells. 1987

A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis

alpha-L-Fucosidase (EC 3.2.1.51; FUS) activity and isoenzyme characteristics were analyzed in normal lymphocytes, normal (polymorphonuclear leukocytes, PMNs), and myeloid and lymphoid leukemic cells. Chronic lymphocytic leukemia (CLL) lymphocytes had a lower mean specific activity than normal lymphocytes (2.5 vs. 4.0, p less than 0.05). Acute lymphoblastic leukemia (ALL) blasts had a higher mean specific activity compared to normal lymphocytes (9.7 vs. 4.0; p less than 0.001), CLL lymphocytes (9.7 vs. 2.5; p less than 0.001), and acute myeloid leukemic (AML) blasts (9.7 vs. 7.6; p = NS). Normal PMNs had a higher mean specific activity than normal lymphocytes (7.0 vs. 4.0; p less than 0.05) but similar activity when compared to CML cells or AML blasts. Blasts from acute myelomonocytic leukemia (AMMoL) patients had higher activity than normal PMNs (9.0 vs. 7.0; p greater than 0.05). The isoenzyme patterns of normal and leukemic granulocytes and lymphocytes were obtained by automated chromatofocusing on PBE-94 microcolumns with normal and leukemic lymphocyte lysates. With normal and leukemic lymphoid lysates two major isoenzyme components (B and A) were isolated. The isoenzyme patterns of PMN, AML, CML, and AMMoL revealed three major peaks (B, A, I), totally different from those seen in lymphoid cells. The patterns of AML, CML, and PMN appeared to be similar to each other; however, the isoenzyme pattern obtained from AMMoL cells could be distinguished from the others by a prominent I peak. Thus, the FUS isoenzyme profile distinguishes the blasts of AMMoL from AML; and AMMol and AML from ALL.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D005644 alpha-L-Fucosidase An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51. Fucosidase,alpha-Fucosidase,alpha Fucosidase,alpha L Fucosidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
December 1975, Developmental biology,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
January 1980, Voprosy meditsinskoi khimii,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
January 1984, Anticancer research,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
May 2015, BMC biotechnology,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
January 1990, Leukemia research,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
February 1983, Clinica chimica acta; international journal of clinical chemistry,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
June 1983, Hiroshima journal of medical sciences,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
August 1976, Clinical genetics,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
January 1978, Clinica chimica acta; international journal of clinical chemistry,
A Orlacchio, and C Emiliani, and P Rambotti, and G B Pioda, and S Davis
December 1976, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!